Latest Blogs, News & Events

ASHP 2017 Round Up: Research, Leadership, and Wine

Another American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting & Exhibition has passed. At ASHP 2017, brilliant pharmacy leaders from around the country united in Orlando, Florida, to discuss today’s most pressing issues, research, and breakthroughs in the industry.

  Read More

Therigy® Announces Strategic Organizational Changes for Greater Scalability...

Maitland, FL — Therigy announced today two key leadership changes within the organization. Lily P. Duong, PharmD, Therigy’s Vice President of Clinical Programs has been promoted to Chief Clinical Officer. Dr. Duong has been responsible for the development of Therigy’s drug therapy management programs and clinical reporting. Lily joined Therigy in 2013 and brought with her many years of clinical operations management and clinical program development. Russel Allinson, RPh, MS, Therigy’s CEO, said of Dr. Duong “It has been an honor to watch Lily grow in her current role over the past several years. Her deep knowledge of the specialty pharmacy industry is expansive and has been invaluable in the development of our clinical programs and collaborating on technology advances. In promoting her to Chief Clinical Officer I know she will continue to lead by example and drive our strategic business efforts forward. Our DNA is about marrying therapy management solutions with technology and this role is perfect fit for her.” Lily received both her B.S and Doctor of Pharmacy degree from Temple University School of Pharmacy. She also holds a B.S. in chemical engineering from Drexel University.

  Read More

How Specialty Pharmacies Can Keep up with Patient Engagement Trends

As the world becomes more digital in the way it communicates and gathers information, specialty pharmacy patients are no exception. Digital experiences are a key to engaging a 21st century audience, and data shows that many specialty pharmacies are using digital strategies to improve patient communication, therapy education, and overall outcomes.

  Read More

The Challenge of Getting Approval for Specialty Drug Therapies and Referral...

One of the roles of specialty pharmacy is to deliver potentially life-altering and often complex therapies as quickly as possible. However, in the industry’s current state, many specialty pharmacies experience lengthy, drawn-out, and complicated approvals that traverse various stakeholders with unique needs and requirements, multiple systems, and different people at different stages of the referral process

  Read More

Therigy® Announces Free Webinar to Assist Specialty Pharmacies in Deliverin...

Differentiation through quantifiable patient outcomes is specialty pharmacy’s new frontier. Specialty therapy management company Therigy will host a webinar to explore current trends and provide actionable insights for pharmacy leaders.

The specialty pharmacy industry continues to boom. McKesson estimates that by 2018, specialty pharmaceuticals will account for half of all U.S. drug spending. As increasingly targeted specialty therapies develop, and more spending is allocated toward them, specialty pharmacies face the growing need to demonstrate quantifiable value in the specialty pharmacy services they provide.

Historically, there has been little research to clearly identify the role specialty pharmacy services play in managing and enhancing patient outcomes as compared to traditional, small molecule, retail drug therapies. Experts assert that a key to unlocking these insights is a stronger focus on real-world data throughout all stages of the care delivery process —from intake to fulfillment to long-term therapy management.

To help specialty pharmacies explore the role real-world data plays in measuring and reporting patient outcomes, as well as how predictive analytics are being leveraged to identify at-risk patients and actively influence these outcomes, Therigy will host a free online educational webinar on Wednesday, Dec. 13, 2017, at 1:00 p.m. EST.

Therigy’s Chief Strategy Officer Jon Hamrick, MBA, will be joined by two leaders in the specialty care space: Sheena Babin, Pharm.D., Ochsner Specialty Pharmacy’s manager of clinical services and business development, and Brian Smith, Pharm.D., Shields Healthcare Solutions’ vice president of clinical services and quality. These three industry leaders will provide critical perspectives on approaching key chronic conditions from a clinical, operations, and data perspective, as well as give insights into how they leveraged these approaches to gain organizational alignment and ultimately improve the health and wellbeing of their patients.

The webinar will explore two case studies into how these organizations delivered, managed, and documented critical outcomes. Dr. Babin will discuss specialty pharmacy’s role in identifying and managing disease activity in rheumatoid arthritis patients, and how this role influenced Ochsner Specialty Pharmacy’s operations and results. Dr. Smith will explore the impact of lipid identification for diabetic patients and how the clinical research and documentation process was performed at Shields Healthcare Solutions.

Specialty pharmacies have established a now-traditional portfolio of services that include patient onboarding and access support, cold-chain and other drug distribution services, clinical service support, education, and data reporting capabilities. While these services have been demonstrated to provide enhanced adherence for patients, increasing competition and stricter payer requirements are pushing specialty pharmacies to differentiate by driving higher adherence rates and better patient outcomes. The ability to systematize data capture and translate outcomes metrics into meaningful stakeholder reports will play an immense role in a specialty pharmacy industry’s success and growth.

“Now more than ever, specialty pharmacies are looking to innovate their services and differentiate themselves to prove their value to all stakeholders, including providers, patients, payers, and pharma,” said Russel Allinson, RPh, MS, Therigy’s co-founder, chief executive officer, and chief clinical officer. “We believe that this perpetual, data-centric innovation will be a driving force in the industry, pushing pharmacies to deliver better, faster, and more impactful experiences that work to improve population health for everyone—not just patients with chronic conditions.”

Are you interested in exploring specialty pharmacy’s role in delivering and documenting quantifiable patient outcomes, how this role is evolving, and how top specialty pharmacies are improving patient outcomes through real-world examples? Save your seat! Register now for Therigy’s free webinar on Wednesday, Dec. 13, 2017 at 1:00 p.m. EST.

  Read More

The Role Specialty Pharmacy Plays in Clinical Research, Real-world Evidence...

The nature of chronic disease presents significant challenges for those who are committed to treating them, from therapy manufacturers to clinicians to patients themselves. Across the board, chronic illnesses are exceptionally difficult to diagnose, monitor, and successfully manage – let alone define the parameters and guidelines for “success” as they relate to each unique patient.

  Read More

What Payers & Manufacturers Look for in Outcomes–and the Why Behind It

In a time where therapy costs and options are escalating rapidly, stakeholders need to know that they’re getting positive results. This can present a challenge for specialty pharmacies, as they work to create and stabilize the various systems and processes needed to effectively measure and communicate their outcomes in an industry that currently lacks universal data standards.

  Read More

Why a Pharmacy Documentation System Is Critical for Clinical Intervention

Research shows that an automated pharmacy care plan providing consistent patient assessment and  monitoring has myriad benefits for a specialty pharmacy’s ability to intervene appropriately and effectively to improve patient outcomes.

  Read More

How Therigy Helps Specialty Pharmacies Stay Competitive

In a soaring industry that favors consolidation and exclusive partnerships, one of a specialty pharmacy’s biggest challenges is staying on top of steep competition. This is especially true when competing against powerhouse brands that are steadily gaining market share.

  Read More

TherigySTM Hepatitis B (HBV) Outreach

We are excited to announce that we’ve added our 24th category to TherigySTM™: Hepatitis B (HBV), which became available on September 30.

  Read More

The Importance of Transparency and Proving Your Specialty Pharmacy’s Outcom...

As the healthcare industry continues to evolve, the name of the game is value. All stakeholders – as well as the public in general – are turning a discerning eye to the quality of care. This goes for public and private sectors: consumers, who are savvier than ever in managing their own health, as well as payers, pharmacy benefit managers (PBMs), and manufacturers, who scrutinize the added criteria of costs and performance while making sure their partners are meeting contractual obligations.

  Read More

Three Strategies to Differentiate Your Specialty Pharmacy from the Competit...

Specialty drugs have skyrocketed to one-third of the pharmacy industry’s revenue. This trend isn’t dying down: by 2020, it’s estimated to comprise half of the market. From small, independent pharmacies to mega retail chains, the industry is seeing diverse participation that stems from a wide variety of provider quality and expertise.

  Read More

Therigy President and COO, Joseph Morse, Appointed to NASP Board of Directo...

Morse Joins Organization for Three-Year Term in Advocating for U.S. NASP Members – Shaping the Future of Specialty Pharmacy Policy

Therigy®, the company that pioneered patient-focused specialty therapy management, is steadfastly committed to helping shape the future of the specialty pharmacy industry. The company has once again proved that its commitment is based on the strength and industry expertise of its people.  Therigy’s President, Chief Operating Officer, and cofounder, Joseph (Joe) Morse, was recently appointed to the 2018 National Association of Specialty Pharmacy (NASP) Board of Directors. With this appointment, Morse, a longtime specialty therapy management thought leader, joins a team of renowned visionaries in specialty pharmacy R&D and manufacturing, technology development, government relations, and public policy with a common vision of shaping the industry’s future. NASP’s Board of Directors is known historically for helping establish specialty pharmacy best practices, monitoring and responding to industry shifts and trends, and advocating for over 1,500 corporate and individual NASP members across the United States.

  Read More

Using Data to Improve Patient Safety

As a healthcare provider, you’ve made a commitment to ensure that every single patient receives the requisite level of care consistent with best practice guidelines while mitigating as many risks as you can foresee. Along with the other duties of care that a healthcare organization pledges, this promise is a complex and demanding one.

  Read More

U.S. House Passes Landmark Legislation for Medicare Home Infusion Reimburse...

In July, the U.S. House of Representatives made strides in improving Medicare programs by passing H.R. 3178, the Medicare Part B Improvement Act of 2017. This legislation consists of three titles with several smaller measures.

  Read More
  Partner with Therigy to conduct outcomes studies based on real-world evidence across 20+ specialty disease states and 400+ specialty medications.
Contact Us Today!